Literature DB >> 33826040

Multigene assessment of genetic risk for women for two or more breast cancers.

Jeffrey N Weitzel1,2, John Kidd3, Ryan Bernhisel3, Susan Shehayeb4, Paul Frankel4, Kathleen R Blazer4, Diana Turco3, Bita Nehoray4, Kim McGreevy3, Kira Svirsky3, Krystal Brown3, Anna Gardiner3, Mary Daly5, Elisha Hughes3, Shelly Cummings3, Jennifer Saam3,6, Thomas P Slavin4,3.   

Abstract

PURPOSE: The prevalence, penetrance, and spectrum of pathogenic variants that predispose women to two or more breast cancers is largely unknown.
METHODS: We queried clinical and genetic data from women with one or more breast cancer diagnosis who received multigene panel testing between 2013 and 2018. Clinical data were obtained from provider-completed test request forms. For each gene on the panel, a multivariable logistic regression model was constructed to test for association with risk of multiple breast cancer diagnoses. Models accounted for age of diagnosis, personal and family cancer history, and ancestry. Results are reported as odds ratios (ORs) with 95% confidence intervals (CIs).
RESULTS: This study included 98,979 patients: 88,759 (89.7%) with a single breast cancer and 10,220 (10.3%) with ≥ 2 breast cancers. Of women with two or more breast cancers, 13.2% had a pathogenic variant in a cancer predisposition gene compared to 9.4% with a single breast cancer. BRCA1, BRCA2, CDH1, CHEK2, MSH6, PALB2, PTEN, and TP53 were significantly associated with two or more breast cancers, with ORs ranging from 1.35 for CHEK2 to 3.80 for PTEN. Overall, pathogenic variants in all breast cancer risk genes combined were associated with both metachronous (OR 1.65, 95% CI 1.53-1.79, p = 7.2 × 10-33) and synchronous (OR 1.33, 95% CI 1.19-1.50, p = 2.4 × 10-6) breast cancers.
CONCLUSIONS: This study demonstrated that several high and moderate penetrance breast cancer susceptibility genes are associated with ≥ 2 breast cancers, affirming the association of two or more breast cancers with diverse genetic etiologies.
© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  BRCA1; BRCA2; Breast cancer; Hereditary breast cancer; Multiple breast cancers; Second breast cancer

Mesh:

Year:  2021        PMID: 33826040      PMCID: PMC8803157          DOI: 10.1007/s10549-021-06201-y

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.624


  44 in total

1.  Common variants associated with breast cancer in genome-wide association studies are modifiers of breast cancer risk in BRCA1 and BRCA2 mutation carriers.

Authors:  Xianshu Wang; V Shane Pankratz; Zachary Fredericksen; Robert Tarrell; Mary Karaus; Lesley McGuffog; Paul D P Pharaoh; Bruce A J Ponder; Alison M Dunning; Susan Peock; Margaret Cook; Clare Oliver; Debra Frost; Olga M Sinilnikova; Dominique Stoppa-Lyonnet; Sylvie Mazoyer; Claude Houdayer; Frans B L Hogervorst; Maartje J Hooning; Marjolijn J Ligtenberg; Amanda Spurdle; Georgia Chenevix-Trench; Rita K Schmutzler; Barbara Wappenschmidt; Christoph Engel; Alfons Meindl; Susan M Domchek; Katherine L Nathanson; Timothy R Rebbeck; Christian F Singer; Daphne Gschwantler-Kaulich; Catherina Dressler; Anneliese Fink; Csilla I Szabo; Michal Zikan; Lenka Foretova; Kathleen Claes; Gilles Thomas; Robert N Hoover; David J Hunter; Stephen J Chanock; Douglas F Easton; Antonis C Antoniou; Fergus J Couch
Journal:  Hum Mol Genet       Date:  2010-04-23       Impact factor: 6.150

2.  RAD51 135G-->C modifies breast cancer risk among BRCA2 mutation carriers: results from a combined analysis of 19 studies.

Authors:  Antonis C Antoniou; Olga M Sinilnikova; Jacques Simard; Mélanie Léoné; Martine Dumont; Susan L Neuhausen; Jeffery P Struewing; Dominique Stoppa-Lyonnet; Laure Barjhoux; David J Hughes; Isabelle Coupier; Muriel Belotti; Christine Lasset; Valérie Bonadona; Yves-Jean Bignon; Timothy R Rebbeck; Theresa Wagner; Henry T Lynch; Susan M Domchek; Katherine L Nathanson; Judy E Garber; Jeffrey Weitzel; Steven A Narod; Gail Tomlinson; Olufunmilayo I Olopade; Andrew Godwin; Claudine Isaacs; Anna Jakubowska; Jan Lubinski; Jacek Gronwald; Bohdan Górski; Tomasz Byrski; Tomasz Huzarski; Susan Peock; Margaret Cook; Caroline Baynes; Alexandra Murray; Mark Rogers; Peter A Daly; Huw Dorkins; Rita K Schmutzler; Beatrix Versmold; Christoph Engel; Alfons Meindl; Norbert Arnold; Dieter Niederacher; Helmut Deissler; Amanda B Spurdle; Xiaoqing Chen; Nicola Waddell; Nicole Cloonan; Tomas Kirchhoff; Kenneth Offit; Eitan Friedman; Bella Kaufmann; Yael Laitman; Gilli Galore; Gad Rennert; Flavio Lejbkowicz; Leon Raskin; Irene L Andrulis; Eduard Ilyushik; Hilmi Ozcelik; Peter Devilee; Maaike P G Vreeswijk; Mark H Greene; Sheila A Prindiville; Ana Osorio; Javier Benitez; Michal Zikan; Csilla I Szabo; Outi Kilpivaara; Heli Nevanlinna; Ute Hamann; Francine Durocher; Adalgeir Arason; Fergus J Couch; Douglas F Easton; Georgia Chenevix-Trench
Journal:  Am J Hum Genet       Date:  2007-10-16       Impact factor: 11.025

3.  Common breast cancer susceptibility alleles and the risk of breast cancer for BRCA1 and BRCA2 mutation carriers: implications for risk prediction.

Authors:  Antonis C Antoniou; Jonathan Beesley; Lesley McGuffog; Olga M Sinilnikova; Sue Healey; Susan L Neuhausen; Yuan Chun Ding; Timothy R Rebbeck; Jeffrey N Weitzel; Henry T Lynch; Claudine Isaacs; Patricia A Ganz; Gail Tomlinson; Olufunmilayo I Olopade; Fergus J Couch; Xianshu Wang; Noralane M Lindor; Vernon S Pankratz; Paolo Radice; Siranoush Manoukian; Bernard Peissel; Daniela Zaffaroni; Monica Barile; Alessandra Viel; Anna Allavena; Valentina Dall'Olio; Paolo Peterlongo; Csilla I Szabo; Michal Zikan; Kathleen Claes; Bruce Poppe; Lenka Foretova; Phuong L Mai; Mark H Greene; Gad Rennert; Flavio Lejbkowicz; Gord Glendon; Hilmi Ozcelik; Irene L Andrulis; Mads Thomassen; Anne-Marie Gerdes; Lone Sunde; Dorthe Cruger; Uffe Birk Jensen; Maria Caligo; Eitan Friedman; Bella Kaufman; Yael Laitman; Roni Milgrom; Maya Dubrovsky; Shimrit Cohen; Ake Borg; Helena Jernström; Annika Lindblom; Johanna Rantala; Marie Stenmark-Askmalm; Beatrice Melin; Kate Nathanson; Susan Domchek; Ania Jakubowska; Jan Lubinski; Tomasz Huzarski; Ana Osorio; Adriana Lasa; Mercedes Durán; Maria-Isabel Tejada; Javier Godino; Javier Benitez; Ute Hamann; Mieke Kriege; Nicoline Hoogerbrugge; Rob B van der Luijt; Christi J van Asperen; Peter Devilee; E J Meijers-Heijboer; Marinus J Blok; Cora M Aalfs; Frans Hogervorst; Matti Rookus; Margaret Cook; Clare Oliver; Debra Frost; Don Conroy; D Gareth Evans; Fiona Lalloo; Gabriella Pichert; Rosemarie Davidson; Trevor Cole; Jackie Cook; Joan Paterson; Shirley Hodgson; Patrick J Morrison; Mary E Porteous; Lisa Walker; M John Kennedy; Huw Dorkins; Susan Peock; Andrew K Godwin; Dominique Stoppa-Lyonnet; Antoine de Pauw; Sylvie Mazoyer; Valérie Bonadona; Christine Lasset; Hélène Dreyfus; Dominique Leroux; Agnès Hardouin; Pascaline Berthet; Laurence Faivre; Catherine Loustalot; Tetsuro Noguchi; Hagay Sobol; Etienne Rouleau; Catherine Nogues; Marc Frénay; Laurence Vénat-Bouvet; John L Hopper; Mary B Daly; Mary B Terry; Esther M John; Saundra S Buys; Yosuf Yassin; Alexander Miron; David Goldgar; Christian F Singer; Anne Catharina Dressler; Daphne Gschwantler-Kaulich; Georg Pfeiler; Thomas V O Hansen; Lars Jønson; Bjarni A Agnarsson; Tomas Kirchhoff; Kenneth Offit; Vincent Devlin; Ana Dutra-Clarke; Marion Piedmonte; Gustavo C Rodriguez; Katie Wakeley; John F Boggess; Jack Basil; Peter E Schwartz; Stephanie V Blank; Amanda Ewart Toland; Marco Montagna; Cinzia Casella; Evgeny Imyanitov; Laima Tihomirova; Ignacio Blanco; Conxi Lazaro; Susan J Ramus; Lara Sucheston; Beth Y Karlan; Jenny Gross; Rita Schmutzler; Barbara Wappenschmidt; Christoph Engel; Alfons Meindl; Magdalena Lochmann; Norbert Arnold; Simone Heidemann; Raymonda Varon-Mateeva; Dieter Niederacher; Christian Sutter; Helmut Deissler; Dorothea Gadzicki; Sabine Preisler-Adams; Karin Kast; Ines Schönbuchner; Trinidad Caldes; Miguel de la Hoya; Kristiina Aittomäki; Heli Nevanlinna; Jacques Simard; Amanda B Spurdle; Helene Holland; Xiaoqing Chen; Radka Platte; Georgia Chenevix-Trench; Douglas F Easton
Journal:  Cancer Res       Date:  2010-11-30       Impact factor: 12.701

4.  Accompanying DCIS in breast cancer patients with invasive ductal carcinoma is predictive of improved local recurrence-free survival.

Authors:  M Dieterich; F Hartwig; J Stubert; S Klöcking; G Kundt; B Stengel; T Reimer; B Gerber
Journal:  Breast       Date:  2014-02-18       Impact factor: 4.380

Review 5.  Counselling framework for moderate-penetrance cancer-susceptibility mutations.

Authors:  Nadine Tung; Susan M Domchek; Zsofia Stadler; Katherine L Nathanson; Fergus Couch; Judy E Garber; Kenneth Offit; Mark E Robson
Journal:  Nat Rev Clin Oncol       Date:  2016-06-14       Impact factor: 66.675

6.  Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.

Authors:  Sue Richards; Nazneen Aziz; Sherri Bale; David Bick; Soma Das; Julie Gastier-Foster; Wayne W Grody; Madhuri Hegde; Elaine Lyon; Elaine Spector; Karl Voelkerding; Heidi L Rehm
Journal:  Genet Med       Date:  2015-03-05       Impact factor: 8.822

7.  Development and analytical validation of a 25-gene next generation sequencing panel that includes the BRCA1 and BRCA2 genes to assess hereditary cancer risk.

Authors:  Thaddeus Judkins; Benoît Leclair; Karla Bowles; Natalia Gutin; Jeff Trost; James McCulloch; Satish Bhatnagar; Adam Murray; Jonathan Craft; Bryan Wardell; Mark Bastian; Jeffrey Mitchell; Jian Chen; Thanh Tran; Deborah Williams; Jennifer Potter; Srikanth Jammulapati; Michael Perry; Brian Morris; Benjamin Roa; Kirsten Timms
Journal:  BMC Cancer       Date:  2015-04-02       Impact factor: 4.430

8.  Somatic TP53 variants frequently confound germ-line testing results.

Authors:  Jeffrey N Weitzel; Elizabeth C Chao; Bita Nehoray; Lily R Van Tongeren; Holly LaDuca; Kathleen R Blazer; Thomas Slavin; D A B M D Facmg; Tina Pesaran; Christina Rybak; Ilana Solomon; Mariana Niell-Swiller; Jill S Dolinsky; Danielle Castillo; Aaron Elliott; Chia-Ling Gau; Virginia Speare; Kory Jasperson
Journal:  Genet Med       Date:  2017-11-30       Impact factor: 8.822

9.  Association of a Polygenic Risk Score With Breast Cancer Among Women Carriers of High- and Moderate-Risk Breast Cancer Genes.

Authors:  Shannon Gallagher; Elisha Hughes; Susanne Wagner; Placede Tshiaba; Eric Rosenthal; Benjamin B Roa; Allison W Kurian; Susan M Domchek; Judy Garber; Johnathan Lancaster; Jeffrey N Weitzel; Alexander Gutin; Jerry S Lanchbury; Mark Robson
Journal:  JAMA Netw Open       Date:  2020-07-01

10.  The prognostic comparison among unilateral, bilateral, synchronous bilateral, and metachronous bilateral breast cancer: A meta-analysis of studies from recent decade (2008-2018).

Authors:  Bo Pan; Ying Xu; Yi-Dong Zhou; Ru Yao; Huan-Wen Wu; Qing-Li Zhu; Chang-Jun Wang; Feng Mao; Yan Lin; Song-Jie Shen; Qiang Sun
Journal:  Cancer Med       Date:  2019-04-30       Impact factor: 4.452

View more
  1 in total

1.  Risk-reducing mastectomy decisions among women with mutations in high- and moderate- penetrance breast cancer susceptibility genes.

Authors:  Jacob G Comeaux; Julie O Culver; John E Lee; Danielle Dondanville; Heather L McArthur; Emily Quinn; Nicholas Gorman; Charité Ricker; Ming Li; Caryn Lerman
Journal:  Mol Genet Genomic Med       Date:  2022-08-25       Impact factor: 2.473

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.